Suppr超能文献

[肠道微生物群——肝脏疾病的重要促成因素]

[Gut microbiota-an important contributor to liver diseases].

作者信息

Wang Fangzhao, Cui Qianru, Zeng Yunong, Chen Peng

机构信息

Department of Pathophysiology, College of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.

出版信息

Nan Fang Yi Ke Da Xue Xue Bao. 2020 Apr 30;40(4):595-600. doi: 10.12122/j.issn.1673-4254.2020.04.23.

Abstract

Gut microbiota constitute a complicated but manifold ecosystem, in which specific symbiotic relationships are formed among various bacteria. To maintain a steady state, the gastrointestinal tract and the liver form a close anatomical and functional two-way, interconnected network through the portal circulation. "Gut-liver axis" plays a key role in the pathogenesis of liver diseases. Accumulating evidence indicates that gut microbiota can influence the liver pathophysiology directly or indirectly via a variety of signal pathways. In a pathological state where an ecological imbalance occurs at the compositional and functional levels, gut microbes would interact with the host immune system and other type of cells to cause liver steatosis, inflammation and fibrosis, which in turn give rise to the development of such liver diseases as alcoholic liver disease, nonalcoholic fatty liver disease, primary sclerosing cholangitis, and acute liver failure, to name a few. Studies have shown that microorganisms, such as prebiotics and probiotics, can improve the prognosis of certain diseases, which open a new era of treating liver diseases with bacteria. There are many unknowns and hidden values in the gut microbiome. To explore the pathophysiological mechanism of various complex diseases and develop scientific and effective clinical treatment strategies, efforts should be made to obtain insights into how certain intestinal microbiota participates in the occurrence and progression of liver diseases. As the connection between gut microbiota and liver diseases at both the acute and chronic phases was not elaborated in previously published review articles, herein we discuss the association between gut microbiota and both acute and chronic liver injury. The anatomical structure of the liver enables it to form a close network with the gut microbiota, which is an important mediator in the regulation of the hepatic physiological and pathological functions.

摘要

肠道微生物群构成了一个复杂但多样的生态系统,其中各种细菌之间形成了特定的共生关系。为了维持稳态,胃肠道和肝脏通过门静脉循环形成了一个紧密的解剖学和功能上的双向互联网络。“肠-肝轴”在肝脏疾病的发病机制中起关键作用。越来越多的证据表明,肠道微生物群可通过多种信号通路直接或间接影响肝脏病理生理学。在组成和功能水平出现生态失衡的病理状态下,肠道微生物会与宿主免疫系统及其他类型的细胞相互作用,导致肝脏脂肪变性、炎症和纤维化,进而引发诸如酒精性肝病、非酒精性脂肪性肝病、原发性硬化性胆管炎和急性肝衰竭等肝脏疾病。研究表明,益生元和益生菌等微生物可改善某些疾病的预后,这开启了用细菌治疗肝脏疾病的新时代。肠道微生物组存在许多未知和潜在价值。为了探索各种复杂疾病的病理生理机制并制定科学有效的临床治疗策略,应努力深入了解某些肠道微生物群如何参与肝脏疾病的发生和发展。由于此前发表的综述文章未阐述肠道微生物群与急慢性肝病阶段的联系,因此我们在此讨论肠道微生物群与急慢性肝损伤之间的关联。肝脏的解剖结构使其能够与肠道微生物群形成紧密网络,而肠道微生物群是调节肝脏生理和病理功能的重要介质。

相似文献

1
[Gut microbiota-an important contributor to liver diseases].[肠道微生物群——肝脏疾病的重要促成因素]
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Apr 30;40(4):595-600. doi: 10.12122/j.issn.1673-4254.2020.04.23.
2
Gut Microbiota Targeted Approach in the Management of Chronic Liver Diseases.靶向肠道微生物群的慢性肝脏疾病管理方法。
Front Cell Infect Microbiol. 2022 Apr 4;12:774335. doi: 10.3389/fcimb.2022.774335. eCollection 2022.
3
Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.肠道微生物群:非酒精性脂肪性肝病的新治疗靶点。
Expert Rev Gastroenterol Hepatol. 2019 Mar;13(3):193-204. doi: 10.1080/17474124.2019.1569513. Epub 2019 Jan 25.
4
Gut microbiome and liver diseases.肠道微生物组与肝脏疾病。
Gut. 2016 Dec;65(12):2035-2044. doi: 10.1136/gutjnl-2016-312729. Epub 2016 Oct 8.
5
[Gut-liver axis: How intestinal bacteria affect the liver].肠-肝轴:肠道细菌如何影响肝脏
MMW Fortschr Med. 2018 Nov;160(Suppl 5):11-15. doi: 10.1007/s15006-018-1051-6. Epub 2018 Oct 26.
7
Gut microbiota and host metabolism in liver cirrhosis.肝硬化中的肠道微生物群与宿主代谢
World J Gastroenterol. 2015 Nov 7;21(41):11597-608. doi: 10.3748/wjg.v21.i41.11597.

引用本文的文献

本文引用的文献

1
Alterations of gut microbiome in autoimmune hepatitis.自身免疫性肝炎中肠道微生物组的改变。
Gut. 2020 Mar;69(3):569-577. doi: 10.1136/gutjnl-2018-317836. Epub 2019 Jun 14.
2
Role of Gut Microbiota in Hepatocarcinogenesis.肠道微生物群在肝癌发生中的作用。
Microorganisms. 2019 May 5;7(5):121. doi: 10.3390/microorganisms7050121.
4
Alcohol, liver disease and the gut microbiota.酒精、肝病与肠道微生物组。
Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):235-246. doi: 10.1038/s41575-018-0099-1.
7
The gut-liver axis and the intersection with the microbiome.肠-肝轴与微生物组的交汇。
Nat Rev Gastroenterol Hepatol. 2018 Jul;15(7):397-411. doi: 10.1038/s41575-018-0011-z.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验